Hamza Abbad is a Tucson, Arizona based neurologist who is specialized in Neurology. Active license number of Hamza Abbad is R78546 for Neurology in Arizona. His current practice location is 1625 N Campbell Ave, Tucson. Patients can reach him at 520-626-3894. Hamza Abbad is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1710567136. Hamza Abbad specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Hamza Abbad speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Hamza Abbad
Specialization:
Neurology
Gender:
Male
Credentials:
MD
Practice Address:
1625 N Campbell Ave, Tucson, Arizona, 85719-4330
Phone:
520-626-3894
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1710567136
NPI Enumeration Date:
09 Apr, 2021
NPI Last Update On:
16 Jun, 2021
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Hamza Abbad are as mentioned below.
License Number
Specialization
State
Status
R78546
Neurology
Arizona
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Hamza Abbad 1625 N Campbell Ave, Tucson, Arizona
Zip:
85719-4330
Patients can reach Hamza Abbad at 1625 N Campbell Ave, Tucson, Arizona or can call to book an appointment on 520-626-3894.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.